-+ 0.00%
-+ 0.00%
-+ 0.00%

Dexcom wins FDA clearance for Stelo glucose biosensor use in children 2 and older

PUBT·06/23/2026 13:01:39
Listen to the news
Dexcom wins FDA clearance for Stelo glucose biosensor use in children 2 and older
  • Dexcom won FDA clearance expanding Stelo’s indication to children aged 2 and older who are not using insulin.
  • Stelo was previously cleared only for adults aged 18 and older not using insulin, widening the addressable US market to pediatric users.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260623413946) on June 23, 2026, and is solely responsible for the information contained therein.